NCT02668185View on ClinicalTrials.gov

Neuropeptide Treatment for Hot Flushes During the Menopause

PHASE2CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

February 1, 2016

Primary Completion Date

January 1, 2017

Study Completion Date

January 1, 2017

Conditions
Menopausal Flushing
Interventions
DRUG

NK3R antagonist - AZD4901

Neurokinin 3 receptor antagonist

DRUG

Placebo

Placebo

Trial Locations (1)

W12 0HS

NIHR/Wellcome Trust Imperial CRF, London

Sponsors
All Listed Sponsors
collaborator

Medical Research Council

OTHER_GOV

collaborator

AstraZeneca

INDUSTRY

collaborator

National Institute for Health Research, United Kingdom

OTHER_GOV

lead

Imperial College London

OTHER